Serial 18F-choline-PET imaging in patients receiving enzalutamide for metastatic castration-resistant prostate cancer: response assessment and imaging biomarkers. Read more about Serial 18F-choline-PET imaging in patients receiving enzalutamide for metastatic castration-resistant prostate cancer: response assessment and imaging biomarkers.
MM-398 (nanoliposomal irinotecan): emergence of a novel therapy for the treatment of advanced pancreatic cancer. Read more about MM-398 (nanoliposomal irinotecan): emergence of a novel therapy for the treatment of advanced pancreatic cancer.
To screen or not to screen older women for breast cancer: a conundrum. Read more about To screen or not to screen older women for breast cancer: a conundrum.
Molecular targets and mechanisms of radiosensitization using DNA damage response pathways. Read more about Molecular targets and mechanisms of radiosensitization using DNA damage response pathways.
Rational therapeutic combinations with histone deacetylase inhibitors for the treatment of cancer. Read more about Rational therapeutic combinations with histone deacetylase inhibitors for the treatment of cancer.
DNA amplifications in breast cancer: genotypic-phenotypic correlations. Read more about DNA amplifications in breast cancer: genotypic-phenotypic correlations.
Aberrant kinase signaling: lessons from head and neck cancer. Read more about Aberrant kinase signaling: lessons from head and neck cancer.
State-of-the-art radiotherapy in the management of clinically localized prostate carcinoma. Read more about State-of-the-art radiotherapy in the management of clinically localized prostate carcinoma.
